These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37486414)

  • 1. Lack of diversity in vitiligo clinical trials: a cross-sectional analysis.
    Hernandez LE; Verling S; Nouri K
    Arch Dermatol Res; 2023 Nov; 315(9):2735-2736. PubMed ID: 37486414
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of camouflage in vitiligo: A cross-sectional survey.
    Poondru S; Kundu RV
    J Cosmet Dermatol; 2023 Dec; 22(12):3524-3526. PubMed ID: 37352455
    [No Abstract]   [Full Text] [Related]  

  • 3. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study.
    Canu D; Shourick J; Andreu N; Gey A; Ballanger-Désolneux F; Barailler H; Boniface K; Ezzedine K; Seneschal J
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e676-e679. PubMed ID: 34013570
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitiligo on YouTube: A cross-sectional analysis.
    Carrington AE; Kitts S; Kleinwaks E; Luu J; Nguyen M; Park JH
    J Am Acad Dermatol; 2022 Jan; 86(1):199-201. PubMed ID: 33508386
    [No Abstract]   [Full Text] [Related]  

  • 5. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological comorbidities of vitiligo: a retrospective cross-sectional analysis in an urban population.
    Montgomery SN; Syder N; Barajas G; Elbuluk N
    Arch Dermatol Res; 2023 Dec; 316(1):14. PubMed ID: 38047925
    [No Abstract]   [Full Text] [Related]  

  • 7. Views on vitiligo disease course and treatment among people living with vitiligo and healthcare providers worldwide.
    Br J Dermatol; 2023 Oct; 189(5):e94. PubMed ID: 37879743
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultra-violet therapy in cases of leucoderma.
    MENON AN
    Ind Med Gaz; 1945 Dec; 80(12):612-4. PubMed ID: 21026566
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitiligo.
    Manoj R; Singh S; Kothari R; Gupta A
    J Am Acad Dermatol; 2024 May; 90(5):1106-1114. PubMed ID: 38184279
    [No Abstract]   [Full Text] [Related]  

  • 10. Current Status of Cell-Based Therapies for Vitiligo.
    Domaszewska-Szostek A; Polak A; Słupecka-Ziemilska M; Krzyżanowska M; Puzianowska-Kuźnicka M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global VALIANT study: 'lifting the lid' on disappointment and frustration with the lack of effective treatment for vitiligo.
    Ahmed A; Eleftheriadou V
    Br J Dermatol; 2023 Nov; 189(6):e99-e102. PubMed ID: 37705206
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 vaccine-associated vitiligo: A cross-sectional study in a tertiary referral center and systematic review.
    Tsai TF; Ng CY
    J Dermatol; 2023 Aug; 50(8):982-989. PubMed ID: 37186102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitiligo.
    Okoro U; Usatine RP; Heath CR
    Cutis; 2023 Feb; 111(2):106-107. PubMed ID: 37075191
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitiligo.
    LeWitt TM; Kundu RV
    JAMA Dermatol; 2021 Sep; 157(9):1136. PubMed ID: 34287629
    [No Abstract]   [Full Text] [Related]  

  • 15. Expanding the White Armor of Vitiligo.
    Pearson TF; Harris JE
    J Invest Dermatol; 2024 Jan; 144(1):5-7. PubMed ID: 37831052
    [No Abstract]   [Full Text] [Related]  

  • 16. Global recommendations for vitiligo management.
    Ring J
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2157-2158. PubMed ID: 37877761
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding the impacts of vitiligo to provide better care.
    Meurant JM
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2161-2162. PubMed ID: 37877765
    [No Abstract]   [Full Text] [Related]  

  • 18. Using methotrexate in the treatment of advanced vitiligo.
    Tavitova A; Valle Y; Lomonosov K
    J Cosmet Dermatol; 2023 Mar; 22(3):1136-1138. PubMed ID: 36409563
    [No Abstract]   [Full Text] [Related]  

  • 19. Axillary incubator for cell-based therapies in vitiligo.
    Bhatia S; Rajput L; Gupta S
    J Am Acad Dermatol; 2021 Nov; 85(5):e279-e280. PubMed ID: 32222452
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitiligo and makeup: analyzing interest and usage trends in the 21st century.
    Syder NC; Elbuluk N
    Int J Dermatol; 2023 Sep; 62(9):e505-e506. PubMed ID: 36691783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.